Intech Investment Management LLC Charles River Laboratories International, Inc. Transaction History

Intech Investment Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Oct 18, 2024	BUY	$191.89 - $259.92 $555,137 - $751,948	2,893 New	2,893 $583,000
Q1 2023 May 10, 2023	SELL	$191.89 - $259.92 $23,218 - $31,450	-121 Reduced 4.01%	2,893 $583,000
Q4 2022 Oct 18, 2024	SELL	$197.11 - $250.07 $7,490 - $9,502	-38 Reduced 1.25%	3,014 $656,000
Q4 2022 Feb 09, 2023	SELL	$197.11 - $250.07 $7,490 - $9,502	-38 Reduced 1.25%	3,014 $656,000
Q3 2022 Oct 18, 2024	BUY	$182.44 - $250.54 $556,806 - $764,648	3,052 New	3,052 $600,000
Q3 2022 Nov 10, 2022	SELL	$182.44 - $250.54 $103,261 - $141,805	-566 Reduced 15.64%	3,052 $601,000
Q2 2022 Aug 10, 2022	BUY	$204.13 - $302.4 $738,542 - $1.09 Million	3,618 New	3,618 $774,000

698

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.1B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Intech Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Intech Investment Management LLC with notifications on news.